Silexion Therapeutics Ltd.SLXNNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank50
Year-over-Year Change
Year-over-year operating cash flow growth rate
Latest
-85.38%
↑ 79% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-406.90%
Historical baseline
| Period | Value |
|---|---|
| 2024 | -85.38% |
| 2023 | -35.80% |
| 2022 | -136.99% |
| 2021 | -1776.31% |
| 2020 | 0.00% |